Poly(butyl methacrylate-co-methacrylic acid) tissue engineering scaffold with pro-angiogenic potential in vivo

被引:24
作者
Butler, Mark J. [1 ]
Sefton, Michael V. [1 ]
机构
[1] Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON, Canada
关键词
tissue engineering; scaffold; vascularization; compression testing; angiogenesis;
D O I
10.1002/jbm.a.31314
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A poly(butyl methacrylate-co-methacrylic acid) (BMA-MAA) scaffold was fabricated by an in situ polymerization solvent casting/particulate leaching technique. It displayed high porosity (85-90%), pore interconnectivity, and a pore size range of 100-650 mu m. Compression testing of the scaffolds demonstrated a dependence of the compressive stiffness on several fabrication variables including the ratio of monomer to salt used during the polymerization, the degree of salt fusion, and the choice of alternative comonomers to BMA. Subcutaneous implantation of BMA-MAA scaffolds in mice revealed an increased level of histological angiogenesis in tissue invading the pores of the scaffold compared to a BMA control, consistent with the prediction that methacrylic acid (MAA) containing copolymer beads are angiogenic in a wound healing context. At postoperative day 21, the capillary density in the BMA-MAA scaffolds was 56 +/- 13/mm 2 as compared to 32 +/- 8/mm 2 for the BMA scaffolds. With further investigation, it is expected that this biornaterial capable of eliciting an angiogenic response will have widespread application in tissue engineering. (c) 2007 Wiley Periodicals, Inc.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 35 条
[1]  
Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
[2]  
Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
[3]   NEOVASCULARIZATION OF SYNTHETIC MEMBRANES DIRECTED BY MEMBRANE MICROARCHITECTURE [J].
BRAUKER, JH ;
CARRBRENDEL, VE ;
MARTINSON, LA ;
CRUDELE, J ;
JOHNSTON, WD ;
JOHNSON, RC .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (12) :1517-1524
[4]  
Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
[5]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[6]   Functions of hyaluronan in wound repair [J].
Chen, WYJ ;
Abatangelo, G .
WOUND REPAIR AND REGENERATION, 1999, 7 (02) :79-89
[7]   BIOCOMPATIBILITY OF POTENTIAL WOUND MANAGEMENT PRODUCTS - FUNGAL MYCELIA AS A SOURCE OF CHITIN/CHITOSAN AND THEIR EFFECT ON THE PROLIFERATION OF HUMAN F1000 FIBROBLASTS IN CULTURE [J].
CHUNG, LY ;
SCHMIDT, RJ ;
HAMLYN, PF ;
SAGAR, BF ;
ANDREWS, AM ;
TURNER, TD .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (04) :463-469
[8]   Angiogenic gene-modified muscle cells for enhancement of tissue formation [J].
De Coppi, P ;
Delo, D ;
Farrugia, L ;
Udompanyanan, K ;
Yoo, JJ ;
Nomi, M ;
Atala, A ;
Soker, S .
TISSUE ENGINEERING, 2005, 11 (7-8) :1034-1044
[9]  
Doi K, 1997, J BIOMED MATER RES, V34, P361, DOI 10.1002/(SICI)1097-4636(19970305)34:3<361::AID-JBM11>3.0.CO
[10]  
2-J